protein COVID-19 vaccine
Selected indexed studies
- COVID-19 vaccine development: milestones, lessons and prospects. (Signal Transduct Target Ther, 2022) [PMID:35504917]
- Self-amplifying RNA COVID-19 vaccine. (Cell, 2024) [PMID:38608649]
- Exosome-Based COVID-19 Vaccine. (Methods Mol Biol, 2023) [PMID:37140804]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- COVID-19 vaccine development: milestones, lessons and prospects. (2022) pubmed
- Self-amplifying RNA COVID-19 vaccine. (2024) pubmed
- Exosome-Based COVID-19 Vaccine. (2023) pubmed
- Covid-19 vaccines and variants of concern: A review. (2022) pubmed
- COVID-19: vaccine's progress. (2021) pubmed
- Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals. (2025) pubmed
- COVID-19 vaccine: where are we now and where should we go? (2021) pubmed
- COVID-19 vaccine decisions: considering the choices and opportunities. (2021) pubmed
- COVID-19 vaccines. (2021) pubmed
- Audio Interview: Covid-19 Vaccine Fundamentals. (2020) pubmed